These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 194689)

  • 21. Epidemiologic variables in prostatic cancer.
    Krain LS
    Geriatrics; 1973 May; 28(5):93-8. PubMed ID: 4739855
    [No Abstract]   [Full Text] [Related]  

  • 22. Genital and urinary tract diseases and prostate cancer risk.
    Pelucchi C; Talamini R; Negri E; Franceschi S; La Vecchia C
    Eur J Cancer Prev; 2006 Jun; 15(3):254-7. PubMed ID: 16679869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Etiological and epidemiological considerations in prostatic cancer.
    Bouffioux CR
    Scand J Urol Nephrol Suppl; 1980; 55():9-16. PubMed ID: 6938042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cancer of the prostate. 1. Epidemiology].
    Mottet Auselo N; Costa P; Le Pellec L; Louis JF; Navratil H
    Prog Urol; 1995 Feb; 5(1):31-7. PubMed ID: 7536526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for invasive carcinoma of the uterine cervix in Latin America.
    Herrero R; Brinton LA; Reeves WC; Brenes MM; Tenorio F; de Britton RC; Gaitán E; Montalván P; García M; Rawls WE
    Bull Pan Am Health Organ; 1990; 24(3):263-83. PubMed ID: 2171706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased frequency of antibodies to ubiquitous viruses in essential mixed cryoglobulinaemia.
    Fiorini G; Bernasconi P; Sinico RA; Chianese R; Pozzi F; D'Amico G
    Clin Exp Immunol; 1986 Apr; 64(1):65-70. PubMed ID: 3015457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case-control study of prostatic cancer in Kyoto, Japan: sexual risk factors.
    Oishi K; Okada K; Yoshida O; Yamabe H; Ohno Y; Hayes RB; Schroeder FH; Boyle P
    Prostate; 1990; 17(4):269-79. PubMed ID: 2251222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship of herpesvirus to carcinoma of the prostate.
    Baker LH; Mebust WK; Chin TD; Chapman AL; Hinthorn D; Towle D
    J Urol; 1981 Mar; 125(3):370-4. PubMed ID: 6259379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology of prostatic cancer: a case-control study.
    Fincham SM; Hill GB; Hanson J; Wijayasinghe C
    Prostate; 1990; 17(3):189-206. PubMed ID: 2235728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiological study of prostatic cancer by matched-pair analysis.
    Mishina T; Watanabe H; Araki H; Nakao M
    Prostate; 1985; 6(4):423-36. PubMed ID: 4088954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sexual behavior and evidence for an infectious cause of prostate cancer.
    Strickler HD; Goedert JJ
    Epidemiol Rev; 2001; 23(1):144-51. PubMed ID: 11588840
    [No Abstract]   [Full Text] [Related]  

  • 33. Epidemiologic association between Gonorrhea and prostatic carcinoma.
    Heshmat MY; Kovi J; Herson J; Jones GW; Jackson MA
    Urology; 1975 Oct; 6(4):457-60. PubMed ID: 1179565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [High risk group for prostatic cancer by matched pair analysis (author's transl)].
    Mishina T; Watanabe H; Araki H; Miyakoda K; Fujiwara T; Kobayashi T; Maegawa M
    Nihon Hinyokika Gakkai Zasshi; 1981 Oct; 72(10):1256-79. PubMed ID: 7328963
    [No Abstract]   [Full Text] [Related]  

  • 35. Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort.
    Bonilla C; Lewis SJ; Martin RM; Donovan JL; Hamdy FC; Neal DE; Eeles R; Easton D; Kote-Jarai Z; Al Olama AA; Benlloch S; Muir K; Giles GG; Wiklund F; Gronberg H; Haiman CA; Schleutker J; Nordestgaard BG; Travis RC; Pashayan N; Khaw KT; Stanford JL; Blot WJ; Thibodeau S; Maier C; Kibel AS; Cybulski C; Cannon-Albright L; Brenner H; Park J; Kaneva R; Batra J; Teixeira MR; Pandha H; Lathrop M; Davey Smith G;
    BMC Med; 2016 Apr; 14():66. PubMed ID: 27044414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An epidemiological reappraisal of the familial aggregation of prostate cancer: a meta-analysis.
    Kiciński M; Vangronsveld J; Nawrot TS
    PLoS One; 2011; 6(10):e27130. PubMed ID: 22073129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical genetics of prostate cancer.
    Kommu S; Edwards S; Eeles R
    Hered Cancer Clin Pract; 2004 Jul; 2(3):111-21. PubMed ID: 20233465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Associations between coronary heart disease, obesity and histological prostate cancer.
    Stamatiou KN; Alevizos AG; Mihas K; Mariolis AD; Michalodimitrakis E; Sofras F
    Int Urol Nephrol; 2007; 39(1):197-201. PubMed ID: 17006736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Length and somatic mosaicism of CAG and GGN repeats in the androgen receptor gene and the risk of prostate cancer in men with benign prostatic hyperplasia.
    Tayeb MT; Clark C; Murray GI; Sharp L; Haites NE; McLeod HL
    Ann Saudi Med; 2004; 24(1):21-6. PubMed ID: 15310009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CYP3A4 and VDR gene polymorphisms and the risk of prostate cancer in men with benign prostate hyperplasia.
    Tayeb MT; Clark C; Haites NE; Sharp L; Murray GI; McLeod HL
    Br J Cancer; 2003 Mar; 88(6):928-32. PubMed ID: 12644831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.